flâneur — a map of the web's best reading

Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications - PMC

pmc.ncbi.nlm.nih.gov · 9,199 words · saved by 1 readers

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Primary site navigation Logged in as: Clinical Implications Corresponding Author: Nora D. Volkow, MD, National Institute on Drug Abuse

JAMA . Author manuscript; available in PMC: 2010 Oct 21. Published in final edited form as: JAMA. 2009 Sep 9;302(10):1084–1091. doi: 10.1001/jama.2009.1308 Evaluating Dopamine Reward Pathway in ADHD Clinical Implications Nora D Volkow Dr Nora D Volkow , MD 1 National Institute on Drug Abuse (Dr Volkow) and Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism (Drs Volkow, Telang, and Ma), Bethesda, Maryland; Medical and Chemistry Departments, Brookhaven National Laboratory, Upton, New York (Drs Wang, Fowler, and Logan, Messrs Pradhan and Wong); Department of Psychiatry

Explore this link on the map →

related reading